公司资料

Assertio 股价、新闻与催化剂

股票代码:: ASRT
交易所:: NASDAQ
行业:: Biopharma
所在地:: United States

股票表现

23.50 USD (+0.13%)

收盘价

最后更新: 2026年6月15日

152M USD

市值

股价为何变动

Current closing-price context is not available for ASRT.

公司概览

业务概览

Assertio is a specialty pharmaceutical company with a portfolio of neurology, pain, and related products. The story is largely about managing a concentrated commercial base while expanding selectively.

所在地与行业分类

Headquartered in the United States and listed on NASDAQ, Assertio sits in specialty biopharma.

商业模式特征

The business depends on product revenue, portfolio management, and the ability to stabilize and grow its commercial assets.

生物医药行业定位

Assertio is a specialty-pharma turnaround name with a story shaped by product mix and execution.

未来催化剂

Assertio’s catalysts are its branded pain and neurology portfolio, including Sympazan and Indocin, plus any capital-allocation or portfolio-optimization update. The market will care more about cash generation and simplification than about big pipeline headlines.